Detail akcie Thermo Fisher Scientific online

Business Summary: Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Thermo Fisher Scientific Inc revenues decreased 5% to $42.86B. Net income decreased 14% to $6B. Revenues reflect Life Sciences Solutions segment decrease of 26% to $9.98B, Speciality Diagnostics segment decrease of 8% to $4.41B, United States segment decrease of 8% to $22.01B, Asia Pacific segment decrease of 3% to $7.87B, Northern America excluded united states segment decrease of 3% to $751M.